GlassScriptPhysician profile
Matthew Riley
NPI 1346777844
$2,368.20
in general payments reported to CMS, 2019-2025
9 companies · $31.04 in 2025
The $31.04 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $841 · 2023: $975 · 2024: $522 · 2025: $31.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,527.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $616.35 | 2022-2025 | Wavewriter Alpha Prime 16, Fixate |
| Nevro Corp. | $503.68 | 2022-2024 | Senza |
| Medtronic, INC. | $454.14 | 2023-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbott Laboratories | $348.24 | 2022-2023 | Proclaim |
| Spr Therapeutics, INC | $118.50 | 2022 | |
| Saluda Medical Americas, INC. | $101.03 | 2022 | |
| Grt US Holding, INC. | $91.13 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $89.57 | 2023 | Iovera |
| Si-Bone, INC. | $45.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.